ResearcherNorthwestern UniversityActive in the last 2 years

Gina M. Connors

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5084338334. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

Exploiting Acquired Drug Resistance in Pancreatic Cancer through Selective Covalent Targeting of MAP2K4/7. Co-author DOI 10.1021/acschembio.6c00580 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Thao D. Pham · 1 shared paper, 2026 · strength 0.32
- Paper Exploiting Acquired Drug Resistance in Pancreatic Cancer through Selective Covalent Targeting of MAP2K4/7. DOI 10.1021/acschembio.6c00580 ↗
Jeffrey H. Becker · 1 shared paper, 2026 · strength 0.32
- Paper Exploiting Acquired Drug Resistance in Pancreatic Cancer through Selective Covalent Targeting of MAP2K4/7. DOI 10.1021/acschembio.6c00580 ↗
Karl A. Scheidt · 1 shared paper, 2026 · strength 0.32
- Paper Exploiting Acquired Drug Resistance in Pancreatic Cancer through Selective Covalent Targeting of MAP2K4/7. DOI 10.1021/acschembio.6c00580 ↗
Hidayatullah G. Munshi · 1 shared paper, 2026 · strength 0.32
- Paper Exploiting Acquired Drug Resistance in Pancreatic Cancer through Selective Covalent Targeting of MAP2K4/7. DOI 10.1021/acschembio.6c00580 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.